Stockreport

Assessing Eledon Pharmaceuticals (ELDN) Valuation After Phase 2 Kidney Transplant Trial Results and Phase 3 Prospects [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF While the main goal was not fully met, the data points to meaningful preservation of kidney function. See our latest analysis for Eledon Pharmaceuticals. Shares of E [Read more]